From July 1, 2023 to July 7, 2023, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 12,096,900 shares, representing 0.87% for CNY 100.01 million under the buyback announced on January 9, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.72 CNY | +4.20% | +4.79% | -54.13% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-54.13% | 705M | |
+41.50% | 6.2B | |
-22.89% | 4.1B | |
+9.36% | 3.41B | |
-19.39% | 2.83B | |
-11.05% | 2.29B | |
+45.24% | 1.93B | |
-7.51% | 1.52B | |
+46.81% | 1.51B | |
-18.04% | 1.49B |
- Stock Market
- Equities
- 002424 Stock
- News Guizhou Bailing Group Pharmaceutical Co., Ltd.
- Tranche Update on Guizhou Bailing Group Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on January 9, 2023.